With this context, Cripto-1 has been suggested like a novel therapeutic target inside a Notch4-driven spontaneous model of TNBC [100]
With this context, Cripto-1 has been suggested like a novel therapeutic target inside a Notch4-driven spontaneous model of TNBC [100]. Specific therapies for treating TNBC by focusing on these embryonic pathways in TICs will become further discussed, providing new opportunities to destroy not only the bulk tumor, but also TICs that initiate and promote the…